Sensoan, Inc.

Sensona, Inc. is a molecular diagnostics company focused on developing ultrafast PCR testing technology. The company leverages nanocrystals and DNA nanotechnology to create its PURE-PCR system, which is designed to achieve test results in approximately 90 seconds. By combining universal heat-assisted lysis with photothermal cycling, the platform seeks to improve speed, energy efficiency, and ease of use compared to traditional PCR instrumentation. The company aims to make molecular testing more accessible across diverse settings, including hospitals, clinical laboratories, and field locations.

This technology is intended to support faster decision-making for infectious disease diagnostics and pathogen detection. By offering a simplified, cartridge-based workflow, Sensona aims to address challenges in point-of-care testing and global health systems. The company is actively pursuing strategic partnerships with healthcare networks, research institutions, and distributors to advance its diagnostic solutions from prototype toward wider commercial availability. Its leadership brings extensive academic and scientific expertise in nanotechnology and nucleic acid amplification methods.